Curve Therapeutics CEO Simon Kerry spoke with Amy Brown of Biotech TV on the background, science, and development plans for the Company. Curve CSO Ali Tavassoli also spoke with Amy for a deep dive on the science behind Curve’s mammalian cell-based Microcycle® discovery platform. Simon’s episode is available here while Ali’s is available here.
Following the award of the Royal Society of Chemistry’s Interdisciplinary Prize, Curve Co-Founder and CSO Ali Tavassoli spoke with Eva Haas of Optimum Strategic Communications for an episode of the Optimum Perspectives podcast. Ali reflects on his scientific journey, from what inspired his passion for science to how he came to meet Curve’s CEO Simon […]
Awarded in recognition of excellence in research and innovation and contribution to scientific progress Reflects the revolutionary potential of Curve’s gene-encoded Microcycle® platform to unlock the therapeutic potential of intracellular targets Southampton, UK, 25 June 2025 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company building a pipeline of innovative cyclic peptide and […]
Bio€quity Europe Bruges, Belgium May 12-14, 2025 Simon Kerry, CEO attending
Anglonordic Life Sciences Conference April 3, 2025 London, UK Simon Kerry, CEO & Cora Griffin, Head of Business Development attending
BIO-Europe Spring March 17-19, 2025 Milan, Italy Cora Griffin, Head of Business Development attending
Curve Perspectives article – Rab Prinjha Rab Prinjha joined Curve Therapeutics in 2024 as Chief R&D Officer, after 25 years at GSK. In this Curve Perspectives article to mark British Science Week, Rab explains why he joined Curve, how Southampton is shaping up as a biotech hub, and the importance of collaboration in the UK […]
Curve Perspectives article – Ali Tavassoli With its powerful Microcycle platform technology, Curve Therapeutics is building a pipeline of innovative drugs with a focus on cancer, immunology and inflammation. Our Co-Founder and Chief Scientific Officer, Ali Tavassoli, explains more. Simon Kerry and I co-founded Curve in 2019 with a vision to transform the lives of […]
JP Morgan 43rd Annual Healthcare Conference 13-16 January 2025 San Francisco, US CEO Simon Kerry and Head of Business Development Cora Griffin attending
2024 has been a transformational year for Curve. We kicked off the year with a significant Series A financing, raising £40.5 million from a world class syndicate which includes our existing blue chip investors Advent Life Sciences and Epidarex Capital, alongside new investment from Pfizer Ventures, Columbus Venture Partners and British Patient Capital. The financing […]
